scholarly journals Monitored COVID-19 mRNA vaccine second doses for people with adverse reactions after the first dose

2022 ◽  
Vol 43 (1) ◽  
pp. 37-39
Author(s):  
Megan C. Gallagher ◽  
Sarah Haessler ◽  
Elizabeth Pecoy-Whitcomb ◽  
Jonathan Bayuk

Background: After Emergency Use Authorization of the coronavirus disease 2019 (COVID-19) vaccines, guidance was provided by the Centers for Disease Control and Prevention that persons with an immediate allergic reaction to a messenger RNA (mRNA) COVID-19 vaccine should be evaluated by an allergist/immunologist before receipt of the second dose. Methods: In vaccinating health-care personnel, we referred those with significant reactions to allergy/immunology specialists so that they could safely receive the second dose. Results: We found that many reactions after the first dose were nonallergic but could be debilitating and a barrier to the second dose. We created a protocol of premedications to allow health-care personnel to safely receive their second mRNA COVID-19 vaccine dose. Conclusion: This protocol is adaptable and can be used in settings where allergy/immunology referral is not immediately available.

2020 ◽  
Vol 68 (7) ◽  
pp. 356-356
Author(s):  
Sarah Foster-Chang ◽  
Jennylynn Balmer

Updated Centers for Disease Control and Prevention (CDC) guidelines for tuberculosis (TB) screening of U.S. health care personnel may change practice.


2021 ◽  
pp. 101053952110147
Author(s):  
Yaena Song ◽  
Linda Ko ◽  
Sou Hyun Jang

This study aimed to examine the types of misinformation spreading in South Korea during the coronavirus disease 2019 (COVID-19) pandemic by exploring the fact-checking posts uploaded on the Korea Centers for Disease Control and Prevention (KCDC) website. We conducted a content analysis of the posts written on the KCDC website titled, “COVID-19: Fact and Issue Check,” from February to August 2020 (n = 81). Two coders individually coded the posts using a codebook. Discrepancies in coding were discussed to reach reconciliation. Fifteen different Korean government agencies used the KCDC platform to refute various topics of COVID-19 misinformation, including policy (42.0%), how to prevent the spread (16.0%), health care professionals (12.3%), testing (11.1%), prevention (self-care) (9.9%), masks (8.6%), confirmed cases (8.6%), statistics (3.7%), self-quarantine (2.5%), and treatment (1.2%). We found that there are more dissemination and correction of nonmedical areas of COVID-19 misinformation than medical areas in Korea. Future studies need to examine to what extent the corrected COVID-19 misinformation has been disseminated on different social media platforms, beyond the KCDC website.


Sign in / Sign up

Export Citation Format

Share Document